Thrombosis and Hemorrhage

Table of Contents:

Section I: COAGULATION AND FIBRINOLYSIS 1 COAGULATION CASCADE: AN OVERVIEW Nancy Swords Jenny and Kenneth G. Mann 2 GENETICS OF COAGULATION PROTEINS Katherine A. High 3 REGULATION OF COAGULATION David A. Lane and Robert K. Andrews 4 THE TISSUE FACTOR PATHWAY OF COAGULATION George J. Broze, Jr. 5 CONTACT ACTIVATION Alvin H. Schmaier 6 FIBRIN FORMATION AND STABILIZATION Charles S. Greenberg 7 FIBRINOLYSIS AND ITS REGULATION Douglas E. Vaughan Section II: PLATELETS 8 REGULATION OF MEGAKARYOCYTOPOIESIS Kenneth Kaushansky 9 PLATELET TURNOVER George L. Dale 10 PLATELET MORPHOLOGY John H. Hartwig 11 PLATELET MEMBRANES AND RECEPTORS Ellinor I. Peerschke and Jos� A. L�pez 12 MECHANISMS OF PLATELET ACTIVATION Michael H. Kroll and Richard Sullivan Section III VESSEL WALL 13 OVERVIEW OF THE ENDOTHELIUM Savvas C. Makrides and Una S. Ryan 14 RESPONSE TO VASCULAR INJURY Gary H. Gibbons 15 INTERACTIONS OF LEUKOCYTES WITH THE VESSEL WALL Rodger P. McEver 16 VON WILLEBRAND FACTOR Zaverio Ruggeri, Jerry L. Ware, and David Ginsburg 17 INTERACTION OF COAGULATION FACTORS WITH THE VESSEL WALL P.N.M. Tijburg, K. Kuwabara and David M. Stern 18 INTERACTION OF THE FIBRINOLYTIC SYSTEM WITH THE VESSEL WALL Edward F. Plow, Tatiana Ugarova and Lindsey A. Miles 19 ENDOTHELIUM-DERIVED VASOACTIVE FACTORS Richard A. Cohen 20 RHEOLOGY Julia M. Ross and Larry V. McIntire Section IV EXPERIMENTAL MODELS 21 EXPERIMENTAL MODELS OF THROMBOSIS AND THROMBOLYSIS H. Vernon Anderson and James T. Willerson 22 GENETIC MODELS OF THROMBOSIS AND HEMORRHAGE Peter Carmeliet Section V CLINICAL APPROACH TO BLEEDING AND THROMBOSIS 23 APPROACH TO BLEEDING Andrew I. Schafer 24 APPROACH TO THROMBOSIS Kenneth A. Bauer 25 ASSESSMENT OF ARTERIAL AND VENOUS THROMBOSIS Mark A. Creager 26 LABORATORY METHODS IN HEMOSTASIS Paula L. Bockenstedt Section VI QUANTITATIVE PLATELET DISORDERS 27 THROMBOTIC MICROANGIOPATHIES: THROMBOTIC THROMBOCYTOPENIC PURPURA AND THE HEMOLYTIC-UREMIC SYNDROME Joel L. Moake 28 ALLOIMMUNE THROMBOCYTOPENIAS Peter J. Newman, Janice G. McFarland, and Richard H. Aster 29 DRUG-INDUCED THROMBOCYTOPENIAS Keith R. McCrae and Douglas B. Cines 30 IMMUNE THROMBOCYTOPENIC PURPURA Robert McMillan and Paul A. Imbach 31 THROMBOCYTOSIS Tiziano Barbui and Guido Finazzi Section VII QUALITATIVE PLATELET DISORDERS 32 CONGENITAL DISORDERS OF PLATELET FUNCTION Lindsay C. Dunlop, Robert K. Andrews, Jos� A. L�pez, and Michael C. Berndt 33 ACQUIRED DISORDERS OF PLATELET FUNCTION Andrew I. Schafer Section VIII DISORDERS OF COAGULATION FACTORS AND FIBRINOLYSIS 34 VON WILLEBRAND DISEASE William C. Nichols, Kathleen A. Cooney, Zaverio Ruggeri and David Ginsburg 35 HEMOPHILIA: FACTOR VIII DEFICIENCY Donna M. DiMichele and David Green 36 OTHER COAGULATION FACTOR DEFICIENCIES Harold R. Roberts, M. Daniel Bingham 37 FACTOR VIII AND OTHER COAGULATION FACTOR INHIBITORS David Green 38 ANTIPHOSPHOLIPID SYNDROME, LUPUS ANTICOAGULANTS AND ANTICARDIOLIPIN ANTIBODIES Barbara M. Alving Section IX THROMBOTIC DISORDERS 39 RELATIONSHIP BETWEEN THROMBOSIS AND ATHEROSCLEROSIS David Dobroski, LeRoy Rabbani, Joseph Loscalzo 40 INHERITED AND ACQUIRED HYPERCOAGULABLE STATES Kenneth A. Bauer 41 ENDOTHELIOPATHIES: CLINICAL MANIFESTATIONS OF ENDOTHELIAL DYSFUNCTION Noyan Gokce, John F. Keaney, Jr. and Joseph A. Vita 42 INTERACTION OF BLOOD AND ARTIFICIAL SURFACES Brian R. Smith and Kenneth A. Ault Section X OTHER DISORDERS OF HEMOSTASIS 43 VASCULAR PURPURA AND DISEASES OF BLOOD VESSELS Martin D. Phillips and Moise L. Levy 44 DISSEMINATED INTRAVASCULAR COAGULATION Eliot C. Williams 45 COAGULOPATHY OF LIVER FAILURE AND VITAMIN K DEFICIENCY Jose Martinez and Carl Barsigian 46 MATERNAL HEMOSTASIS: COAGULATION PROBLEMS OF PREGNANCY D. Ware Branch and Bryan Oshiro 47 NEONATAL THROMBOSIS AND HEMORRHAGE Alan D. Michelson 48 HEMOSTATIC COMPLICATIONS OF HIV INFECTION James D. Levine and Jerome E. Groopman 49 HEMOSTATIC COMPLICATIONS OF BONE MARROW TRANSPLANTATION Philip L. McCarthy Jr. and Michael H. Kroll 50 EFFECTS OF CARDIOPULMONARY BYPASS ON HEMOSTASIS Shukri Khuri, M.D., Alan D. Michelson, and C. Robert Valeri Section XI MANAGEMENT OF BLEEDING 51 PLATELET TRANSFUSION THERAPY Scott Murphy 52 PLASMA COMPONENT THERAPY Carlo Brugnara and W. Hallowell Churchill 53 NONTRANSFUSIONAL MODALITIES Pier Mannuccio Mannucci Section XII MANAGEMENT OF THROMBOSIS 54 PHARMACOLOGY OF ANTIPLATELET AGENTS Carlo Patrono 55 PHARMACOLOGY OF HEPARIN AND ORAL ANTICOAGULANTS Jawed Fareed 56 PHARMACOLOGY OF THROMBOLYTIC AGENTS John F. Keany, Jr and Joseph Loscalzo 57 NEWER ANTITHROMBOTIC STRATEGIES Jane E. Freedman and Joseph Loscalzo 58 ANTITHROMBOTIC THERAPY IN CEREBROVASCULAR DISEASE Gregory J. del Zoppo 59 ANTITHROMBOTIC THERAPY IN CARDIOVASCULAR DISEASE Glenn N. Levine and M. Nadir Ali 60 ANTICOAGULANTS IN ATRIAL FIBRILLATION Michael D. Ezekowitz, Ira S. Cohen, and Charles C. Gornick 61 PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE Charles W. Francis 62 GENE THERAPY OF THROMBOTIC AND HEMORRHAGIC DISORDERS Elizabeth G. Nabel INDEX